Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)

Recruiting Observational Study
Prostate Cancer
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
45 – 70
Sex
Male
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Heinrich-Heine University, Duesseldorf · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim of the PSA-Cap study is to test the comparability of measurements of total PSA in serum from venipuncture and in serum from capillary blood using anonymized diagnostic blood samples from patients. Furthermore, a stability test of the samples is carried out after storage at room temperature for 24, 72/96 and 168 hours. Particular attention is paid to the comparability of the measurement res…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Men aged from 45 to 70 years * Informed consent for PSA measurement for prostate cancer screening Exclusion Criteria: * Patients unable to give consent
Contacts

Martin Wallisch

+49 015751187144

martin.wallisch@med.uni-duesseldorf.de

CONTACT